Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is NeuPath Health, Inc. ?
1
Negative results in Jun 25
- DEBT-EQUITY RATIO (HY) Highest at 39.55 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 138.89%, its profits have fallen by -23%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is NeuPath Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
NeuPath Health, Inc.
-100.0%
1.94
59.30%
S&P/TSX 60
19.1%
1.25
15.27%
Quality key factors
Factor
Value
Sales Growth (5y)
28.33%
EBIT Growth (5y)
26.58%
EBIT to Interest (avg)
-0.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.93%
ROE (avg)
0.16%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
0.90
EV to EBIT
11.56
EV to EBITDA
5.30
EV to Capital Employed
0.92
EV to Sales
0.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.93%
ROE (Latest)
0.93%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 2.61 MM
RAW MATERIAL COST(Y)
Fallen by -1.61% (YoY
NET SALES(Q)
Highest at CAD 23.63 MM
OPERATING PROFIT(Q)
Highest at CAD 1.66 MM
OPERATING PROFIT MARGIN(Q)
Highest at 7.02 %
PRE-TAX PROFIT(Q)
Highest at CAD 0.9 MM
NET PROFIT(Q)
Highest at CAD 0.54 MM
-1What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 39.55 %
Here's what is working for NeuPath Health, Inc.
Pre-Tax Profit
At CAD 0.9 MM has Grown at 491.42%
over average net sales of the previous four periods of CAD 0.15 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CAD MM)
Net Profit
At CAD 0.54 MM has Grown at 17,641.73%
over average net sales of the previous four periods of CAD 0 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CAD MM)
Operating Cash Flow
Highest at CAD 2.61 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Net Sales
Highest at CAD 23.63 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Net Sales
At CAD 23.63 MM has Grown at 26.61%
over average net sales of the previous four periods of CAD 18.66 MMMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Operating Profit
Highest at CAD 1.66 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Operating Profit Margin
Highest at 7.02 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CAD 0.9 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 0.54 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
Raw Material Cost
Fallen by -1.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NeuPath Health, Inc.
Debt-Equity Ratio
Highest at 39.55 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






